Tag Archives: FBP

Best Medical Stocks To Watch For 2019

Ionis Pharmaceuticals Inc. (NASDAQ: IONS) shares were relatively flat on Wednesday after the company announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases.

Ultimately, this collaboration will leverage Ionis’s leadership in RNA-targeted therapeutics to develop IONIS-FB-LRx targeting Factor B (FB) for a broad range of diseases.

The first indication the two companies will pursue is the treatment of patients with geographic atrophy (GA), the advanced stage of dry age-related macular degeneration. A Phase 2 study in patients with GA is planned to begin in early 2019.

In the Phase 1 study in 54 healthy volunteers, IONIS-FB-LRx reduced plasma FB and was safe and well tolerated.

Brett P. Monia, chief operating officer at Ionis, commented:

Ionis is committed to bringing new therapies to patients living with unmet medical needs. The collaboration is designed to maximize both the potential benefit to patients and the likelihood of success, while optimizing our commercial participation in IONIS-FB-LRx. This new agreement builds upon our productive relationship with Roche on IONIS-HTTRx (RG6042), an antisense drug for the treatment of people with Huntington’s disease. Our antisense technology is the first to demonstrate robust, dose-dependent and sustained reduction of FB in a clinical study. We believe that we have found the right partner whose experience in retinal disease drug development and commercialization will enhance our efforts to effectively develop IONIS-FB-LRx for patients who currently have no adequate treatment options.

Best Medical Stocks To Watch For 2019: Harmonic Inc.(HLIT)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Harmonic Inc  (NASDAQ:HLIT)Q4 2018 Earnings Conference CallFeb. 04, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Harmonic Inc. (NASDAQ:HLIT) Director William F. Reddersen acquired 5,000 shares of the company’s stock in a transaction that occurred on Monday, May 21st. The stock was purchased at an average cost of $3.99 per share, with a total value of $19,950.00. Following the acquisition, the director now directly owns 199,574 shares of the company’s stock, valued at approximately $796,300.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Harmonic (HLIT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Harmonic (NASDAQ: HLIT) and Commscope (NASDAQ:COMM) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership.

  • [By Ethan Ryder]

    Harmonic (NASDAQ:HLIT) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Thursday.

  • [By Ethan Ryder]

    Vuzix (NASDAQ: HLIT) and Harmonic (NASDAQ:HLIT) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings and dividends.

Best Medical Stocks To Watch For 2019: International Business Machines Corporation(IBM)

Advisors’ Opinion:

  • [By Anders Bylund, Timothy Green, and Dan Caplinger]

    Anders Bylund (IBM): I know, IBM isn’t supposed to get growth investors all excited. The technology veteran has seen nothing but shrinking revenues over the last five years alongside stable profits, at best. Over the same period, stock prices fell 29% lower and IBM investors missed out on a 70% growth spurt in the broader market.

  • [By Timothy Green]

    Here’s an illustration of what Qualcomm was up against. Alphabet’s Google announced in early 2016 that it was developing an open server architecture that would support POWER chips from International Business Machines (NYSE:IBM). POWER was already supported across Google’s toolchain at that time, so the effort began even earlier. It took until March of this year for Google to announce that POWER chips had been deployed in its data centers, and that deployment is likely small at the moment.

  • [By Keith Noonan]

    It might not be easy to find companies that have non-prohibitive valuations, substantial dividend components, and solid underlying businesses with the potential to outperform expectations. But they are out there. Here’s why I think The Walt Disney Company (NYSE:DIS), International Business Machines (NYSE:IBM), and General Motors (NYSE:GM) are three stocks in this mold that can help middle-aged investors build a golden nest egg.

  • [By ]

    One of the foremost leaders in the smart software space is IBM (NYSE: IBM).

    The company’s main AI initiative, Watson, is designed to process massive amounts of unstructured data, learn from it and provide decision support for humans.

  • [By Douglas A. McIntyre]

    An IBM (NYSE: IBM) hardware system was used to help complete the project.

    ALSO READ: 12 American Companies That Control Tech

  • [By Dan Caplinger]

    Yet not every stock in the Dow has done a good job of pulling its weight during the bull market. Some former components, like General Electric and General Motors, have been removed from the average in part because of their poor performance. Yet even among those stocks that have survived the past 10 years and remain in the Dow today, ExxonMobil (NYSE:XOM), IBM (NYSE:IBM), and Walmart (NYSE:WMT) have badly lagged behind most of their peers within the average.

Best Medical Stocks To Watch For 2019: ENGlobal Corporation(ENG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Enigma (CURRENCY:ENG) traded 0.8% lower against the dollar during the 24-hour period ending at 22:00 PM E.T. on October 4th. Over the last week, Enigma has traded 5.9% lower against the dollar. Enigma has a market capitalization of $44.86 million and approximately $1.25 million worth of Enigma was traded on exchanges in the last 24 hours. One Enigma token can currently be purchased for $0.60 or 0.00009137 BTC on popular cryptocurrency exchanges including Huobi, ABCC, Kyber Network and Binance.

  • [By Max Byerly]

    ENGlobal (NASDAQ:ENG) will be announcing its earnings results before the market opens on Wednesday, May 9th.

    ENGlobal (NASDAQ:ENG) last released its quarterly earnings data on Thursday, March 15th. The construction company reported ($0.08) earnings per share for the quarter. ENGlobal had a negative net margin of 29.16% and a negative return on equity of 17.18%. The firm had revenue of $14.43 million during the quarter.

  • [By Stephan Byrd]

    Enigma (CURRENCY:ENG) traded 0.7% higher against the US dollar during the 24 hour period ending at 10:00 AM ET on June 17th. During the last seven days, Enigma has traded down 12% against the US dollar. Enigma has a market capitalization of $104.94 million and $2.86 million worth of Enigma was traded on exchanges in the last 24 hours. One Enigma token can now be bought for about $1.40 or 0.00021533 BTC on popular cryptocurrency exchanges including HitBTC, Vebitcoin, OKEx and GOPAX.

Best Medical Stocks To Watch For 2019: Village Super Market Inc.(VLGEA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub lowered shares of Village Super Market (NASDAQ:VLGEA) from a hold rating to a sell rating in a report published on Tuesday.

    Shares of VLGEA stock opened at $27.20 on Tuesday. Village Super Market has a 52-week low of $21.95 and a 52-week high of $31.49. The company has a quick ratio of 1.38, a current ratio of 1.81 and a debt-to-equity ratio of 0.16. The firm has a market capitalization of $392.70 million, a price-to-earnings ratio of 13.80 and a beta of 0.04.

  • [By Joseph Griffin]

    Media stories about Village Super Market, Inc. Class A (NASDAQ:VLGEA) have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Village Super Market, Inc. Class A earned a news impact score of 0.06 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 43.9608995956738 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Logan Wallace]

    Village Super Market, Inc. Class A (NASDAQ: VLGEA) and Koninklijke Ahold (OTCMKTS:ADRNY) are both retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.

  • [By Shane Hupp]

    BidaskClub upgraded shares of Village Super Market (NASDAQ:VLGEA) from a sell rating to a hold rating in a research report report published on Tuesday.

Best Medical Stocks To Watch For 2019: Intec Pharma Ltd.(NTEC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Intec Pharma Ltd (NASDAQ:NTEC) – Analysts at Oppenheimer decreased their FY2019 EPS estimates for Intec Pharma in a research note issued to investors on Monday, March 4th. Oppenheimer analyst J. Olson now expects that the biotechnology company will post earnings of ($1.18) per share for the year, down from their previous forecast of ($1.04). Oppenheimer has a “Buy” rating and a $15.00 price objective on the stock. Oppenheimer also issued estimates for Intec Pharma’s FY2020 earnings at ($1.19) EPS, FY2021 earnings at ($1.56) EPS, FY2022 earnings at $0.28 EPS and FY2023 earnings at $1.18 EPS.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Intec Pharma (NTEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Intec Pharma (NTEC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Headlines about Intec Pharma (NASDAQ:NTEC) have trended somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Intec Pharma earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 45.4513319646459 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Joseph Griffin]

    Intec Pharma (NASDAQ:NTEC) has been assigned a $15.00 target price by Oppenheimer in a research note issued to investors on Wednesday. The firm presently has a “buy” rating on the biotechnology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 185.71% from the company’s current price.

  • [By Ethan Ryder]

    Media stories about Intec Pharma (NASDAQ:NTEC) have been trending somewhat positive on Wednesday, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Intec Pharma earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 45.6707447165993 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Best Medical Stocks To Watch For 2019: First BanCorp.(FBP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Prudential Financial Inc. lessened its position in First BanCorp (NYSE:FBP) by 16.5% in the first quarter, Holdings Channel reports. The institutional investor owned 906,869 shares of the bank’s stock after selling 179,820 shares during the period. Prudential Financial Inc.’s holdings in First BanCorp were worth $5,459,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Press coverage about First BanCorp (NYSE:FBP) has trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. First BanCorp earned a daily sentiment score of 0.17 on Accern’s scale. Accern also assigned news headlines about the bank an impact score of 47.5369094230747 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Ethan Ryder]

    First Bancorp (NYSE:FBP) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a report issued on Friday.

  • [By Stephan Byrd]

    Shares of First Bancorp (NYSE:FBP) have earned an average rating of “Buy” from the eight brokerages that are presently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages that have covered the stock in the last year is $9.63.

  • [By Ethan Ryder]

    Voya Investment Management LLC lowered its position in First Bancorp (NYSE:FBP) by 83.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 400,520 shares of the bank’s stock after selling 1,959,886 shares during the period. Voya Investment Management LLC owned approximately 0.19% of First Bancorp worth $3,064,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Invest In 2019

Medical marijuana legalization could be the solution to America’s ongoing opioid epidemic, and that could unlock better than 85% profits for savvy investors…

“You don’t need me to tell you that we’re in the middle of a huge and growing opioid crisis. I’m almost certain you’ve seen the statistics – and you’ve likely seen the evidence yourself,” Money Morning Director of Technology & Venture Capital Research Michael A. Robinson said on June 28, 2017.

From funding substance abuse programs to criminal justice-related costs, the opioid crisis has a staggering economic burden of $78.5 billion, according a 2015 U.S. Department of Health & Human Services (HHS) report.

However, legalizing medical marijuana could be a way to cut the cost of the pricey epidemic, reduce the number of addictions, and provide a profit opportunity for forward-thinking investors.

Top 10 Medical Stocks To Invest In 2019: LaSalle Hotel Properties(LHO)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
    MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
    Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
    Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
    Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
    Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
    Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
    Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
    LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
    HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares jumped 113.5 percent to $0.6737 after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares rose 35.34 percent to close at $3.32.
    Art's-Way Manufacturing Co., Inc. (NASDAQ: ARTW) shares gained 30.36 percent to $3.65.
    Xtant Medical Holdings, Inc. (NYSE: XTNT) shares jumped 25.6 percent to $7.4701 after the company disclosed that it has received the FDA clearance for InTice™-C Porous Titanium Cervical Interbody System.
    VAALCO Energy, Inc. (NYSE: EGY) shares surged 20 percent to $2.495.
    TransGlobe Energy Corporation (NASDAQ: TGA) surged 17.04 percent to $2.61.
    Boxlight Corporation (NASDAQ: BOXL) gained 15 percent to $8.32 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the development of next generation interactive educational activities.
    Arcimoto, Inc. (NASDAQ: FUV) gained 15 percent to $3.39.
    MB Financial, Inc. (NASDAQ: MBFI) rose 13.7 percent to $49.64. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    FRONTEO, Inc. (NASDAQ: FTEO) shares rose 11.8 percent to $20.956.
    TransEnterix, Inc. (NYSE: TRXC) shares jumped 11.1 percent to $3.38.
    21Vianet Group, Inc. (NASDAQ: VNET) rose 10.6 percent to $7.41.
    NII Holdings, Inc. (NASDAQ: NIHD) shares gained 9 percent to $2.32.
    Kelly Services, Inc. (NASDAQ: KELYA) rose 7.6 percent to $24.19. Northcoast Research upgraded Kelly Services from Neutral to Buy.
    LaSalle Hotel Properties (NYSE: LHO) shares climbed 5.6 percent to $33.70. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Alteryx, Inc. (NYSE: AYX) gained 5.5 percent to $32.56. KeyBanc upgraded Alteryx from Sector Weight to Overweight.
    Energizer Holdings, Inc. (NYSE:
  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on LaSalle Hotel Properties (LHO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Boenning Scattergood reaffirmed their hold rating on shares of LaSalle Hotel Properties (NYSE:LHO) in a research report report published on Friday.

  • [By Paul Ausick]

    LaSalle Hotel Properties (NYSE: LHO) fell about 14% Wednesday to post a new 52-week low of $24.00 after closing at $28.25 on Tuesday. The 52-week high is $31.75. Volume of about 12.2 million was more than 10 times the daily average. The company’s results were hit hard by Hurricane Irma.

Top 10 Medical Stocks To Invest In 2019: Panasonic Corporation (PCRFY)

Advisors’ Opinion:

  • [By ]

    The production issue for batteries may improve with added input from partner Panasonic (OTCPK:PCRFY). They currently produce battery cells for Tesla in Nevada, and in Japan. At their recent earnings call CEO Kazuhiro Tsuga said they were looking at manufacturing battery cells at a new plant in China in conjunction with Tesla. They also predicted their automation energy business profit would double this year. This can be seen as a vote of confidence in Tesla and a bullish sign for Tesla stock. However, according to reports in the Nikkei Asian Review, there is as yet no definite commitment for a joint venture in China. Panasonic is the world’s largest battery supplier for EV’s.

  • [By ]

    However, Panasonic (OTCPK:PCRFY) announced this week that it was happy to consider further investment in the Nevada facility. A similar move in China is not unlikely. Tesla expects to triple its energy storage business this year but its problem has been getting supply to meet the demand. Panasonic’s announcement is probably connected to a very substantial energy storage contract win just announced by the company.

  • [By SEEKINGALPHA.COM]

    JOLED is a company that was established in 2014 by by Japan Display, Sony (NYSE:SNE) and Panasonic (OTCPK:PCRFY). And they are not the only ones:

    During an OLED display Seminar in Korea, UniJet’s CEO Kim Seok-Soon said that new advances in Ink-Jet printing technologies could enable displays that are over 500 PPI – and so make printing a viable technology to produce small and medium-sized OLED panels.

  • [By Ethan Ryder]

    Panasonic (OTCMKTS:PCRFY) was downgraded by equities researchers at ValuEngine from a “sell” rating to a “strong sell” rating in a research note issued to investors on Thursday.

  • [By ]

    CBAK is in a very competitive industry, as well as being small relative to its competitors. Among the Company’s competitors are giants like Panasonic (OTCPK:PCRFY) and Samsung (OTC:SSNLF), but overall it faces competition from Japan, Korea, and China. Although CBAK states that “we are able to leverage our low-cost advantage to compete favorably with our competitors”, it is hard to see that being the reality, especially when looking at the above gross margins. Still, the Company may enjoy lower labor costs, since it sources labor locally and apparently it has “higher consistency and safety in product quality, which enables us to compete favorably with local competitors”. But given the greater resources of at least some of its competitors and the constantly evolving dynamics of the industry, competition is surely a risk factor to consider.

Top 10 Medical Stocks To Invest In 2019: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By Keith Speights]

    But if you really prioritize dividend payments, Johnson & Johnson isn’t the best choice. It’s not even the top pick in the healthcare arena. When it comes to dividends, I think investors should look to AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) instead of J&J.

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Todd Campbell]

    In this prerecorded episode of Industry Focus: Healthcare, host Kristine Harjes and Motley Fool contributor Todd Campbell dive into the world of drug competition. With real-world examples from companies like Merck (NYSE:MRK), AbbVie (NYSE:ABBV), Gilead Sciences (NASDAQ:GILD), and so many more, the hosts explain what investors need to watch to compare similar drugs. Tune in to learn more about the four most important factors to consider — efficacy, safety, price, and convenience.

  • [By Chris Lange]

    The number of shares short in AbbVie Inc. (NYSE: ABBV) increased to 24.10 million, up from the previous 18.77 million. The stock was trading at $102.52, in a 52-week range of $65.61 to $125.86.

  • [By Keith Speights]

    I’m biased. I wanted to mention that right out of the gate before discussing whether AbbVie (NYSE:ABBV) is a buy. I’ve owned AbbVie for a while and have a favorable view of the big drugmaker’s long-term prospects. However, I’m not oblivious to the challenges AbbVie faces. 

  • [By Keith Speights]

    Which drugs rank at the top of EvaluatePharma’s list? Here are the five biggest blockbusters of the future — and the five companies that are poised to profit from these drugs: AbbVie (NYSE:ABBV), Merck (NYSE:MRK), Celgene (NASDAQ:CELG), Bristol-Myers Squibb (NYSE:BMY), and Pfizer (NYSE:PFE). 

Top 10 Medical Stocks To Invest In 2019: First BanCorp.(FBP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Press coverage about First BanCorp (NYSE:FBP) has trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. First BanCorp earned a daily sentiment score of 0.17 on Accern’s scale. Accern also assigned news headlines about the bank an impact score of 47.5369094230747 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Ethan Ryder]

    Voya Investment Management LLC lowered its position in First Bancorp (NYSE:FBP) by 83.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 400,520 shares of the bank’s stock after selling 1,959,886 shares during the period. Voya Investment Management LLC owned approximately 0.19% of First Bancorp worth $3,064,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    First Bancorp (NYSE:FBP) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a report issued on Friday.

Top 10 Medical Stocks To Invest In 2019: New Media Investment Group Inc.(NEWM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    New Media Inv Group (NYSE: NEWM) and News (NASDAQ:NWS) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on New Media Investment Group (NEWM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Jane Street Group LLC bought a new stake in New Media Investment Group Inc (NYSE:NEWM) in the second quarter, Holdings Channel reports. The fund bought 31,929 shares of the company’s stock, valued at approximately $590,000.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on New Media Investment Group (NEWM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Formed in 2007, New Media Investment Group (NYSE: NEWM) has spent over $1 billion building its portfolio — acquiring 145 daily newspapers and 340 weekly newspapers across 37 states with a combined reach of over 4 million. Throw in the 538 websites and GateHouse Media, the holding company for New Media, reaches over 22 million people in the United States each week and serves over 200,000 business customers through advertising and related marketing services.

Top 10 Medical Stocks To Invest In 2019: IDT Corporation(IDT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    IDT (NYSE: IDT) and Swisscom (OTCMKTS:SCMWY) are both utilities companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends.

  • [By Stephan Byrd]

    Swisscom (OTCMKTS: SCMWY) and IDT (NYSE:IDT) are both utilities companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation.

  • [By Shane Hupp]

    Liberty Sirius XM Group Series A (NASDAQ: LSXMA) and IDT (NYSE:IDT) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk and analyst recommendations.

Top 10 Medical Stocks To Invest In 2019: Valley National Bancorp(VLY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Valley National Bank (NYSE:VLY) announced a quarterly dividend on Tuesday, May 22nd, RTT News reports. Stockholders of record on Friday, June 15th will be paid a dividend of 0.11 per share by the financial services provider on Tuesday, July 3rd. This represents a $0.44 annualized dividend and a dividend yield of 3.39%.

  • [By Shane Hupp]

    New Mexico Educational Retirement Board reduced its position in Valley National Bancorp (NYSE:VLY) by 14.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,100 shares of the financial services provider’s stock after selling 10,700 shares during the quarter. New Mexico Educational Retirement Board’s holdings in Valley National Bancorp were worth $755,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Ethan Ryder]

    Swiss National Bank lifted its position in Valley National Bank (NYSE:VLY) by 21.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 544,300 shares of the financial services provider’s stock after purchasing an additional 94,600 shares during the period. Swiss National Bank owned about 0.16% of Valley National Bank worth $6,782,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Medical Stocks To Invest In 2019: Empire State Realty Trust, Inc.(ESRT)

Advisors’ Opinion:

  • [By ]

    For example, nobody is going to come along and build another Empire State Building. In fact, you can actually invest in this building through the Empire State Realty Trust (NYSE: ESRT). 

  • [By Logan Wallace]

    These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:

    Get Empire State Realty Trust alerts:

    Empire State Realty Trust Inc (ESRT) Receives Consensus Rating of “Hold” from Brokerages (americanbankingnews.com) Empire State Realty Trust, Inc. (NYSE:ESRT): Tracking the Average Broker Recommendation on This Stock (cantoncaller.com) Empire State Realty Trust Inc (ESRT) Shares Sink -1.41% Over Past Five Sessions (cantoncaller.com) Brokerage Overview of: Empire State Realty Trust inc (NYSE:ESRT) (newburghpress.com) Zacks: Analysts Anticipate Empire State Realty Trust Inc (ESRT) Will Announce Quarterly Sales of $123.37 Million (americanbankingnews.com)

    ESRT opened at $17.55 on Wednesday. The firm has a market cap of $2.94 billion, a P/E ratio of 18.28, a P/E/G ratio of 4.93 and a beta of 0.90. Empire State Realty Trust has a fifty-two week low of $15.94 and a fifty-two week high of $21.09. The company has a debt-to-equity ratio of 0.97, a current ratio of 7.10 and a quick ratio of 7.10.

  • [By Logan Wallace]

    Citadel Advisors LLC grew its holdings in Empire State Realty Trust Inc (NYSE:ESRT) by 109.7% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,444,342 shares of the real estate investment trust’s stock after purchasing an additional 1,801,601 shares during the quarter. Citadel Advisors LLC’s holdings in Empire State Realty Trust were worth $58,899,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Prudential Financial Inc. cut its stake in Empire State Realty (NYSE:ESRT) by 0.5% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,745,889 shares of the real estate investment trust’s stock after selling 8,046 shares during the quarter. Prudential Financial Inc.’s holdings in Empire State Realty were worth $29,313,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Empire State Realty Trust (ESRT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Empire State Realty Trust, Inc. (NYSE:ESRT), a leading real estate investment trust (REIT), owns, manages, operates, acquires and repositions office and retail properties in Manhattan and the greater New York metropolitan area, including the Empire State Building, the world's most famous building. Headquartered in New York, New York, the Company's office and retail portfolio covers 10.1 million rentable square feet, as of March 31, 2018, consisting of 9.4 million rentable square feet in 14 office properties, including nine in Manhattan, three in Fairfield County, Connecticut, and two in Westchester County, New York; and approximately 700,000 rentable square feet in the retail portfolio.

Top 10 Medical Stocks To Invest In 2019: Duff & Phelps Utilities Income, Inc.(DNP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Stratos Wealth Partners LTD. lifted its holdings in DNP Select Income Fund Inc. Common Stock (NYSE:DNP) by 108.1% during the first quarter, Holdings Channel reports. The institutional investor owned 17,485 shares of the investment management company’s stock after purchasing an additional 9,084 shares during the period. Stratos Wealth Partners LTD.’s holdings in DNP Select Income Fund Inc. Common Stock were worth $180,000 as of its most recent filing with the SEC.

Top 10 Medical Stocks To Invest In 2019: Juniper Pharmaceuticals, Inc.(JNP)

Advisors’ Opinion:

  • [By Chris Lange]

    Juniper Pharmaceuticals Inc. (NASDAQ: JNP) shares rallied early on Tuesday after the company announced that it would be acquired by Catalent. The transaction is expected to close in the third quarter of 2018.